10 things you should know about the new malaria vaccine

The vaccine, Mosquirix, has been 30 years in the making and was developed by pharmaceutical giant,  GlaxoSmithKline.

___4007815___https:______static.pulse.com.gh___webservice___escenic___binary___4007815___2015___7___24___11___mosquito_3384407b

Earlier on, news broke about the all-new malaria vaccinewhich has been approved for use in Africa.

The vaccine, Mosquirix, has been 30 years in the making and was developed by pharmaceutical giant,  GlaxoSmithKline.

The European Medicines Agency gave a positive scientific opinion after assessing the vaccine's safety and effectiveness, and in October, the Word Health Organisation will decide whether it should be deployed.

Here are 10 things you should know about the new malaria vaccine.

JOIN OUR PULSE COMMUNITY!

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng

Recommended articles

Buhari postpones scheduled medical trip to London

We’re proud of Ajimobi, even in death - Oyo APC

President Buhari constitutes Board of Federal Housing Authority

Delta Senator Nwaoboshi dumps PDP for APC

INEC launches online portal for CVR; begins physical registration July 19

Boko Haram terrorism has claimed 350,000 lives in Nigeria, UN reports

COVID-19: NCDC registers 26 new infections, total now 167,401

JAMB has released 2021 UTME results

Gov Okowa says no one will make him quarrel with his predecessors